Esophageal Cancer Clinical Trials

The goal of our clinical research program at Virginia Mason Franciscan Health is to provide you with a research option at every step of your disease, from initial diagnosis to long-term follow-up. 

The Cancer Institute collaborates with Benaroya Research Institute and the Center for Digestive Health to offer esophageal cancer studies. Our trials include the use of chemotherapy, radiation and targeted therapies, as well quality of life and symptom-management trials.

Learn more about our current esophageal clinical trials:

Temporal Variation in Exhaled Volatile Organic Compounds in Response to Therapeutic Intervention in Esophageal Cancer Patients 

Evaluation of the Lasting Symptoms After Esophageal Resection (LASER) questionnaire in esophageal disease

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Phase 2 Study of ZW25 Plus First-line Combination Chemotherapy in HER2-Expressing Gastroesophageal Adenocarcinoma (GEA)

VM BRITE: A Tissue Registry and Specimen Repository to Support Future Research Projects

To talk with a clinical research coordinator about clinical research trials related to esophageal cancer, call the Cancer Clinical Research Unit Research hotline at 206-287-6270.